| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LGND | Common Stock | Options Exercise | $249K | +4.98K | +9.57% | $49.99 | 57.1K | Sep 20, 2024 | Direct | |
| transaction | LGND | Common Stock | Sale | -$653K | -6.28K | -11% | $104.10 | 50.8K | Sep 20, 2024 | Direct | F1 |
| transaction | LGND | Common Stock | Options Exercise | $19.7K | +395 | +0.78% | $49.99 | 51.2K | Sep 23, 2024 | Direct | |
| transaction | LGND | Common Stock | Options Exercise | $495K | +9.38K | +18.32% | $52.84 | 60.5K | Sep 23, 2024 | Direct | |
| transaction | LGND | Common Stock | Sale | -$248K | -2.48K | -4.1% | $100.05 | 58.1K | Sep 23, 2024 | Direct | F2 |
| transaction | LGND | Common Stock | Sale | -$720K | -7.09K | -12.21% | $101.61 | 51K | Sep 23, 2024 | Direct | F3 |
| transaction | LGND | Common Stock | Sale | -$20.5K | -201 | -0.39% | $102.05 | 50.8K | Sep 23, 2024 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LGND | Employee Stock Option (right to buy) | Options Exercise | $0 | -4.98K | -92.65% | $0.00 | 395 | Sep 20, 2024 | Common Stock | 4.98K | $49.99 | Direct | F5 |
| transaction | LGND | Employee Stock Option (right to buy) | Options Exercise | $0 | -395 | -100% | $0.00 | 0 | Sep 23, 2024 | Common Stock | 395 | $49.99 | Direct | F5 |
| transaction | LGND | Employee Stock Option (right to buy) | Options Exercise | $0 | -9.38K | -18.1% | $0.00 | 42.4K | Sep 23, 2024 | Common Stock | 9.38K | $52.84 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.4300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $100.0000 to $100.2750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $101.0450 to $102.0400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $102.0450 to $102.0950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer. |
| F6 | This Option was previously reported as a Grant of 30,189 shares on May 5, 2022, at an exercise price of $90.68 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer and shall be fully vested on February 5, 2026. |